proteomes Review Misincorporation Proteomics Technologies: A Review Joel R. Steele 1,2 , Carly J. Italiano 2 , Connor R. Phillips 2, Jake P. Violi 1,2, Lisa Pu 2 , Kenneth J. Rodgers 2 and Matthew P. Padula 1,* 1 Proteomics Core Facility and School of Life Sciences, The University of Technology Sydney, Ultimo, NSW 2007, Australia;
[email protected] (J.R.S.);
[email protected] (J.P.V.) 2 Neurotoxin Research Group, School of Life Sciences, The University of Technology Sydney, Ultimo, NSW 2007, Australia;
[email protected] (C.J.I.);
[email protected] (C.R.P.);
[email protected] (L.P.);
[email protected] (K.J.R.) * Correspondence:
[email protected] Abstract: Proteinopathies are diseases caused by factors that affect proteoform conformation. As such, a prevalent hypothesis is that the misincorporation of noncanonical amino acids into a pro- teoform results in detrimental structures. However, this hypothesis is missing proteomic evidence, specifically the detection of a noncanonical amino acid in a peptide sequence. This review aims to outline the current state of technology that can be used to investigate mistranslations and misincor- porations whilst framing the pursuit as Misincorporation Proteomics (MiP). The current availability of technologies explored herein is mass spectrometry, sample enrichment/preparation, data analysis techniques, and the hyphenation of approaches. While many of these technologies show potential, our review reveals a need for further development and refinement of approaches is still required. Keywords: misincorporation; non protein amino acids; post translational modifications Citation: Steele, J.R.; Italiano, C.J.; 1.